| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
12,993 |
11,920 |
$875K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
16,731 |
15,301 |
$848K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
3,853 |
3,796 |
$117K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
889 |
881 |
$63K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
768 |
748 |
$63K |
| X5622 |
|
1,987 |
1,900 |
$55K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
522 |
518 |
$50K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
422 |
415 |
$37K |
| 36415 |
Collection of venous blood by venipuncture |
9,960 |
9,195 |
$36K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
6,657 |
6,574 |
$34K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
452 |
446 |
$30K |
| 99215 |
Prolong outpt/office vis |
246 |
241 |
$30K |
| 92015 |
Determination of refractive state |
1,865 |
1,840 |
$24K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
319 |
317 |
$20K |
| 92551 |
|
2,776 |
2,741 |
$19K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
415 |
403 |
$16K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
792 |
757 |
$15K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
603 |
585 |
$14K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
164 |
163 |
$13K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,197 |
1,174 |
$13K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,449 |
1,371 |
$12K |
| 90686 |
|
2,462 |
2,423 |
$11K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,718 |
1,608 |
$11K |
| 80061 |
Lipid panel |
777 |
766 |
$10K |
| 99188 |
|
1,304 |
1,296 |
$10K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,044 |
1,033 |
$9K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
677 |
649 |
$5K |
| 84443 |
Thyroid stimulating hormone (TSH) |
304 |
298 |
$5K |
| 90834 |
Psychotherapy, 45 minutes with patient |
47 |
29 |
$3K |
| 97810 |
|
109 |
56 |
$3K |
| 99173 |
|
2,493 |
2,446 |
$3K |
| 87081 |
|
821 |
775 |
$3K |
| 0004A |
|
67 |
66 |
$2K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
16 |
15 |
$2K |
| 97811 |
|
108 |
56 |
$2K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
65 |
61 |
$2K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
65 |
61 |
$2K |
| 71046 |
Radiologic examination, chest; 2 views |
115 |
107 |
$2K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
74 |
71 |
$2K |
| 0072A |
|
28 |
28 |
$1K |
| 96127 |
|
250 |
246 |
$971.11 |
| 81001 |
|
378 |
357 |
$871.22 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
121 |
114 |
$683.42 |
| 0071A |
|
17 |
17 |
$640.16 |
| 36416 |
|
212 |
208 |
$501.45 |
| 83718 |
|
61 |
59 |
$497.70 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
12 |
12 |
$430.12 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
92 |
92 |
$427.53 |
| 80053 |
Comprehensive metabolic panel |
38 |
37 |
$383.75 |
| G0008 |
Administration of influenza virus vaccine |
25 |
24 |
$352.27 |
| 99177 |
|
51 |
51 |
$322.61 |
| 90656 |
|
60 |
58 |
$255.14 |
| 82465 |
|
62 |
59 |
$254.62 |
| 0011A |
|
12 |
12 |
$134.24 |
| 85018 |
|
48 |
48 |
$93.00 |
| 87210 |
|
25 |
25 |
$72.58 |
| 81025 |
|
15 |
15 |
$8.95 |
| 90734 |
|
38 |
37 |
$0.00 |
| 90670 |
|
199 |
196 |
$0.00 |
| 90633 |
|
39 |
39 |
$0.00 |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
13 |
13 |
$0.00 |
| 90707 |
|
13 |
13 |
$0.00 |
| 90716 |
|
26 |
26 |
$0.00 |
| 90651 |
|
16 |
16 |
$0.00 |
| 80047 |
|
15 |
12 |
$0.00 |
| 90647 |
|
63 |
63 |
$0.00 |
| 90677 |
|
12 |
12 |
$0.00 |
| 90723 |
|
56 |
54 |
$0.00 |